TrialAnatolian journal of cardiology2025

Pharmaco-Invasive Strategy with Half-Dose Recombinant Human Prourokinase Versus Primary Percutaneous Coronary Intervention.

Chao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.